|
|||||
|
|
A Comparative Analysis of SARS-CoV-2 Antivirals Characterizes 3CLpro Inhibitor PF-00835231 as a Potential New Treatment for COVID-19 |
|
| Authors: | Maren de Vries,Adil S. Mohamed,Rachel A. Prescott,Ana M. Valero-Jimenez,Ludovic Desvignes,Rebecca O’ Connor,Claire Steppan,Joseph C. Devlin,Ellie Ivanova,Alberto Herrera,Austin Schinlever,Paige Loose,Kelly Ruggles,Sergei B. Koralov,Annaliesa S. Anderson,Joseph Binder,Meike Dittmann |
| Abstract: | |
| Keywords: | |